Xiaoyao Ma Selected Research

peiminine

1/2022	Multi-omics analysis reveals the mechanisms of action and therapeutic regimens of traditional Chinese medicine, Bufei Jianpi granules: Implication for COPD drug discovery.
1/2019	Analyze and Identify Peiminine Target EGFR Improve Lung Function and Alleviate Pulmonary Fibrosis to Prevent Exacerbation of Chronic Obstructive Pulmonary Disease by Phosphoproteomics Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyao Ma Research Topics

Disease

8	Inflammation (Inflammations) 01/2022 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2019
2	Hypersensitivity (Allergy) 01/2022 - 12/2021
2	Pain (Aches) 01/2022 - 12/2021
2	Acute Lung Injury 01/2020 - 01/2016
2	Infections 01/2020 - 05/2016
2	Chronic Bronchitis 05/2016 - 01/2016
1	Hypercholesterolemia 08/2022
1	Atherosclerosis 08/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2022
1	Bronchiectasis 01/2022
1	Pulmonary Embolism 01/2022
1	Airway Remodeling 01/2022
1	Fever (Fevers) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Hyperaldosteronism (Conn Syndrome) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Hyperhidrosis 07/2017
1	Spasm (Spasms) 02/2017
1	Asthma (Bronchial Asthma) 11/2016
1	Pulmonary Edema 05/2016
1	Pneumonia (Pneumonitis) 05/2016
1	Necrosis 05/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 05/2016
1	Cough 01/2016

Drug/Important Bio-Agent (IBA)

3	Ursolic AcidIBA 08/2022 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2016
2	peiminineIBA 01/2022 - 01/2019
2	LipopolysaccharidesIBA 01/2022 - 01/2016
2	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2022 - 01/2020
2	AMPA Receptors (AMPA Receptor)IBA 01/2022 - 12/2021
2	CytokinesIBA 01/2020 - 05/2016
2	Caspase 3 (Caspase-3)IBA 01/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
2	Mitogen-Activated Protein KinasesIBA 01/2019 - 01/2016
1	LDL CholesterolIBA 08/2022
1	oxidized low density lipoproteinIBA 08/2022
1	Terpenes (Terpenoids)IBA 08/2022
1	Carboxylic AcidsIBA 08/2022
1	CholesterolIBA 08/2022
1	GoldIBA 01/2022
1	astragaloside AIBA 01/2022
1	shiononeIBA 01/2022
1	pachymic acidIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	bufei jianpiIBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Complex MixturesIBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022
1	CalcineurinIBA 01/2022
1	EnzymesIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	atractylenolide IIBA 01/2022
1	AldosteroneIBA 01/2022
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	swertiamarinIBA 01/2020
1	GinsenosidesIBA 01/2019
1	SmogIBA 01/2019
1	Guanosine Triphosphate (GTP)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	mahuannin BIBA 07/2017
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 07/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2017
1	AlkaloidsIBA 02/2017
1	Chemokine CCL5IBA 05/2016
1	ChemokinesIBA 05/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	CollagenIBA 01/2016
1	jie-geng-tangIBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2016